Enrolment | Allocation | Post-allocation | Close-up | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Time point | Pregnancy | Pregnancy | Pregnancy | Delivery | Postpartum | Postpartum | |||||
19–23.6 weeks | 19–23.6 weeks | 21–24.6 weeks | 24–36 weeks | 34–36.6 weeks | 36–38 weeks | 1–3 months | 12 months | 24 months | 24 months | ||
Screening visit | Randomization visit | Initial visit | Interventions | Final visit | Extra visit | Postnatal follow-up | |||||
Enrollment: | |||||||||||
Eligibility screen | √ | ||||||||||
Informed consent | √ | ||||||||||
Allocation | √ | ||||||||||
Interventions: | |||||||||||
MD | √ | ||||||||||
MBSR program | √ | ||||||||||
Usual care | √ | ||||||||||
Assessments: | |||||||||||
Baseline variables | |||||||||||
Sociodemographic data | √ | ||||||||||
Medical history | √ | √ | |||||||||
Maternal life-style assessment | √ | √ | √ | √ | |||||||
Maternal nutritional assessment | √ | √ | |||||||||
Outcome variables | |||||||||||
Primary outcome | √ | ||||||||||
Perinatal outcomes | √ | √ | |||||||||
Infant Bayley-III | √ | √ | |||||||||
Infant cardiovascular assessment | √ | √ | |||||||||
Other variables | |||||||||||
Biological samples: | |||||||||||
Maternal biological samples | √ | √ | √ | √ | |||||||
Feto-placental biological samples | √ | ||||||||||
Infant biological samples | √ | √ | |||||||||
Maternal and fetal imaging: | |||||||||||
Feto-placental US assessment | √ | ||||||||||
EFW and feto-placental Doppler | √ | ||||||||||
Fetal echocardiography | √ | ||||||||||
Fetal neurosonography | √ | ||||||||||
Maternal and fetal magnetic resonance rimaging | √ | ||||||||||
Infant extra tests: | |||||||||||
Infant NBAS | √ | ||||||||||
Infant ASQ | √ |